Lymphoma Clinical Trials

As one of the nation’s leading academic medical centers, UT Southwestern Medical Center takes part in a variety of clinical trials aimed at improving the outcomes of patients with different types of lymphoma.

Current lymphoma trials at UT Southwestern include:

• Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
• NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma
• Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
• M9177: Phase II Study of Dose-Adjusted EPOCH+/- Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma

Patients should speak with their doctor about opportunities to participate in a clinical trial.